On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Moyamoya disease diagnosis and treatment

TopicLeading institutions, researchers & key papers

Moyamoya disease diagnosis and treatment is a topic indexed in ScholarIQ from OpenAlex.

What is known about Moyamoya disease diagnosis and treatment?

ScholarIQrecord summary

This cluster of papers represents current research on Moyamoya disease and syndrome, focusing on genetic susceptibility (RNF213 gene), revascularization surgery, neurological complications, and epidemiological features. It covers a wide range of topics including the clinical features, treatment outcomes, genetic factors, and long-term prognosis of Moyamoya disease. The research also explores the pathophysiology, neurocognitive effects, and vascular development associated with this cerebrovascular disease.

How many works does Moyamoya disease diagnosis and treatment have?

ScholarIQindexed works

Moyamoya disease diagnosis and treatment has 102 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Moyamoya disease diagnosis and treatment?

ScholarIQopenalex

The OpenAlex for Moyamoya disease diagnosis and treatment is on the source record.

What are the most-cited papers on Moyamoya disease diagnosis and treatment?

ScholarIQmost cited works
Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development
Wanyang Liu, Daisuke Morito, Seiji Takashima, Yohei Mineharu, Hatasu Kobayashi, Toshiaki Hitomi, Hirokuni Hashikata, Norio Matsuura, Satoru Yamazaki, Atsushi Toyoda, Ken‐ichiro Kikuta, Yasushi Takagi, Kouji H. Harada, Asao Fujiyama, Roman Herzig, Boris Krischek, Li‐Ping Zou, Jeong Eun Kim, Masafumi Kitakaze, Susumu Miyamoto, Kazuhiro Nagata, Nobuo Hashimoto, Akio Koizumi
PLoS ONE. 2011725 CitationsOPEN ACCESS
Effects of Extracranial–Intracranial Bypass for Patients With Hemorrhagic Moyamoya Disease
Susumu Miyamoto, Takashi Yoshimoto, Nobuo Hashimoto, Yasushi Okada, Ichiro Tsuji, Teiji Tominaga, Jyoji Nakagawara, Jun Takahashi, Keisuke YAMADA, Yasutake Tomata, Tsuguya Fukui, Yasuo Fukuuchi, Takashi Ohmoto, Yasuo Kuwabara, Izumi Nagata, Junichi Ono, Toshio Machida, Ryuji Sakakibara, Kanji Yamane, Shinji OKITA, Toru Iwama, Yasuhiko Kaku, Nobuhito Saito, Hidenao Fukuyama, Kiyohiro Houkin, Satoshi Kuroda, Ichiro Yabe, Fumio Moriwaka, Akira Ogawa, Kuniaki Ogasawara, Kenji Yoshida, Kiyotaka Fujii, Masaru Yamada, Kimitoshi Sato, Tsugio Akutsu, Sen Yamagata, Shigekazu Takeuchi, Kentarō Hayashi, Nobutaka Horie, Kazuo Yamada, Toshiaki Osato, Toshiichi Watanabe, Kaori Honjo, Kazuya Sako, Hiroyuki Nakase, Shoichiro Kawaguchi, Fumihiko Nisimura, Junichi Yamao, Hiroaki Naritomi, Tooru Inoue, Hiroshi Abe, Akifumi Suzuki, Tatsuya Ishikawa, Yoshinori Akiyama, Toshihiko Suenaga, Miki Fujimura, Shinji Nagahiro, Masaaki Uno, Kyoko Nishi, Junichiro Satomi, Yoshikazu Okada, Akiji Kawashima, Kohji Yamaguchi, Yukiko Tsutsumi
Stroke. 2014647 CitationsOPEN ACCESS
Intraoperative control of extracranial—intracranial bypass patency by near-infrared indocyanine green videoangiography
Johannes Woitzik, Péter Horn, Peter Vajkoczy, Peter Schmiedek
Journal of neurosurgery. 2005263 Citations
Pediatric moyamoya disease: An analysis of 410 consecutive cases
Seung‐Ki Kim, Byung‐Kyu Cho, Ji Hoon Phi, Ji Yeoun Lee, Jong‐Hee Chae, Ki Joong Kim, Yong‐Seung Hwang, I. O. Kim, Dong Soo Lee, Joongyub Lee, Kyu‐Chang Wang
Annals of Neurology. 2010215 Citations
Significance of the Hemorrhagic Site for Recurrent Bleeding
Jun Takahashi, Takeshi Funaki, Kiyohiro Houkin, Tooru Inoue, Kuniaki Ogasawara, Jyoji Nakagawara, Satoshi Kuroda, Keisuke YAMADA, Susumu Miyamoto, the JAM Trial Investigators, Takashi Yoshimoto, Nobuo Hashimoto, Ichiro Tsuji, Yasutake Tomata, Tsuguya Fukui, Yasushi Okada, Masayasu Matsumoto, Tsuguya Fukui, Ichiro Tsuji, Yasuo Fukuuchi, Takashi Ohmoto, Yasuo Kuwabara, Izumi Nagata, Junichi Ono, Toshio Machida, Ryuji Sakakibara, Kanji Yamane, Shinji OKITA, Kiyoshi Kumano, Toru Iwama, Yasuhiko Kaku, Nobuhito Saito, Hidenao Fukuyama, Ichiro Yabe, Fumio Moriwaka, Akira Ogawa, Kenji Yoshida, Kiyotaka Fujii, Masaru Yamada, Kimitoshi Sato, Tsugio Akutsu, Sen Yamagata, Shigekazu Takeuchi, Izumi Nagata, Kentarō Hayashi, Nobutaka Horie, Kazuo Yamada, Hiroyuki Katano, Atsuo Masago, Toshiaki Osato, Toshiichi Watanabe, Kaori Honjo, Kazuya Sako, Hiroyuki Nakase, Shoichiro Kawaguchi, Fumihiko Nishimura, Junichi Yamao, Hiroaki Naritomi, Yasushi Okada, Hiroshi Abe, Akifumi Suzuki, Tatsuya Ishikawa, Yoshinori Akiyama, Toshihiko Suenaga, Teiji Tominaga, Miki Fujimura, Shinji Nagahiro, Masaaki Uno, Kyoko Nishi, Junichiro Satomi, Yoshikazu Okada, Akitsugu Kawashima, Koji Yamaguchi, Tatsuya Ishikawa, Takakazu Kawamata, Yukiko Tsutsumi
Stroke. 2015140 CitationsOPEN ACCESS

Where is Moyamoya disease diagnosis and treatment research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Moyamoya disease diagnosis and treatment is open access?

ScholarIQopen access share
47%OPEN ACCESS
Gold
20%
Green
0%
Hybrid
0%
Bronze
27%
Closed
53%

Related on ScholarIQ

470M+ articles · 14-day free trial